Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 31 Similar Profiles
Medicaid Medicine & Life Sciences
Prescriptions Medicine & Life Sciences
Medication Adherence Medicine & Life Sciences
Health Expenditures Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
Antidepressive Agents Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2005 2016

Research Output 2004 2018

Continuity of medication management among adults with schizophrenia and comorbid cardiometabolic conditions

Hansen, R. A., Hohmann, N., Maciejewski, M. L., Domino, M. E., Ray, N., Mahendraratnam, N. & Farley, J. F. Mar 1 2018 In : Journal of Pharmaceutical Health Services Research. 9, 1, p. 13-20 8 p.

Research output: Contribution to journalArticle

Hospital Emergency Service
Schizophrenia
Inpatients
Psychiatry
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperkalemia
Angiotensin Receptor Antagonists
Secondary Prevention
Angiotensin-Converting Enzyme Inhibitors
Acute Kidney Injury

Continuity of medication management in Medicaid patients with chronic comorbid conditions: An examination by mental health status

Farley, J. F., Hansen, R. A., Domino, M. E., Borse, M., Mahendraratnam, N., Ray, N. & Maciejewski, M. L. Mar 1 2017 In : General Hospital Psychiatry. 45, p. 25-31 7 p.

Research output: Contribution to journalArticle

Medicaid
Health Status
Schizophrenia
Mental Health
Depression
5 Citations

CYP2C19-guided antiplatelet therapy: A cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention

Borse, M. S., Dong, O. M., Polasek, M. J., Farley, J. F., Stouffer, G. A. & Lee, C. R. Aug 1 2017 In : Pharmacogenomics. 18, 12, p. 1155-1166 12 p.

Research output: Contribution to journalArticle

clopidogrel
Pharmacogenetics
Percutaneous Coronary Intervention
Cost-Benefit Analysis
Genotype

Do medical homes offer improved diabetes care for medicaid enrollees with co-occurring schizophrenia?

Olesiuk, W. J., Farley, J. F., Domino, M. E., Ellis, A. R., Morrissey, J. P., Lichstein, J. C., Beadles, C. A., Jackson, C. T. & DuBard, C. A. Jan 1 2017 In : Journal of health care for the poor and underserved. 28, 3, p. 1030-1041 12 p.

Research output: Contribution to journalArticle